Coherus Oncology
CHRS
CHRS
93 hedge funds and large institutions have $627M invested in Coherus Oncology in 2017 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 44 increasing their positions, 24 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
26% less call options, than puts
Call options by funds: $1.43M | Put options by funds: $1.92M
57% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 21
Holders
93
Holding in Top 10
–
Calls
$1.43M
Puts
$1.92M
Top Buyers
| 1 | +$87.5M | |
| 2 | +$18.5M | |
| 3 | +$7.05M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$6.13M |
| 5 |
JPMorgan Chase & Co
New York
|
+$4.85M |
Top Sellers
| 1 | -$25.9M | |
| 2 | -$8.9M | |
| 3 | -$3.87M | |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$3.24M |
| 5 |
CCI
Columbus Circle Investors
|
-$2.73M |